Post by Taros Discovery

⚠️ Carcinogenic traces in pharmaceuticals: An often invisible risk with major implications for patient safety, pharmaceutical quality, and regulatory compliance. Our latest publication in Nachrichten aus der Chemie explores the sources, risks, and regulatory challenges surrounding nitrosamines in pharmaceutical products. Co-authored by Dr. Helmut Buschmann, Dr. Ranjit Kulkarni, Ph.D. & Youri Mesmoudi. At Taros Chemicals, we are committed to combining scientific excellence with regulatory expertise to address critical challenges in pharmaceutical development. 📖 Read the German article here: https://lnkd.in/ei697Cmz #TarosChemicals #Pharma #Nitrosamines #DrugSafety #RegulatoryScience #QualityManagement #PatientSafety #PharmaceuticalIndustry #ChemicalInnovation #LifeSciences